Evidence map›Paper›PMID 33519947›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Analysis of the Anti-Inflammatory and Analgesic Mechanism of Shiyifang Vinum Based on Network Pharmacology.

Hui Tian, Linli Wei, Yunxiu Yao, Zhaoqing Zeng, Xue Liang, Hua Zhu

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Role of Organic Small Molecules in Pain Management.Molecules (Basel, Switzerland) · 2021
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hui TianGuangxi University for Nationalities, Nanning 530006, China.ORCID https://orcid.org/0000-0003-2031-1300
Linli WeiGuangxi University of Chinese Medicine, Nanning 530200, China.ORCID https://orcid.org/0000-0001-6323-5884
Yunxiu YaoGuangxi University of Chinese Medicine, Nanning 530200, China.ORCID https://orcid.org/0000-0003-0168-7433
Zhaoqing ZengGuangxi University of Chinese Medicine, Nanning 530200, China.ORCID https://orcid.org/0000-0001-5338-2442
Xue LiangGuangxi University of Chinese Medicine, Nanning 530200, China.ORCID https://orcid.org/0000-0001-8184-9011
Hua ZhuGuangxi University for Nationalities, Nanning 530006, China.ORCID https://orcid.org/0000-0002-6533-5173

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe possible core active compounds and potential mechanism of action of Shiyifang Vinum were explored through network pharmacology and

methodsWe screened the core active components and the action targets of Shiyifang Vinum through the TCMSP database and literature mining and drew a Venn map of the intersection with anti-inflammatory and analgesic-related gene targets. Go and KEGG analyses were enriched with the David database. The compound target pathway network was constructed using Cytoscape 3.6.1. The binding strength of core active compounds and target proteins was verified through molecular docking, and the direct effects of Shiyifang Vinum and four monomer compounds on COX-2 enzyme activity were detected through an

results14 active compounds and 11 targets were screened out from Shiyifang Vinum through TCMSP database and literature mining; 252 GO entries were obtained by GO analysis, and 114 signal pathways were screened by KEGG analysis. The results of the molecular docking showed that the core compounds and target proteins had strong binding activity.

conclusionThis study preliminarily explored the potential active compounds and target proteins of the anti-inflammatory and analgesic effects of Shiyifang Vinum, which could provide a scientific basis for further study on the anti-inflammatory and analgesic mechanism and material basis of this recipe.

Identifiers

PMID33519947
PMCPMC7817263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.